Perrigo Company plc - Form 8-K Summary
Business Context and Reporting Period
Perrigo Company plc, incorporated in Ireland, filed this Current Report on Form 8-K on February 27, 2018. The filing announces the release of preliminary unaudited financial results for the calendar year ended December 31, 2017. The detailed earnings information is contained in the attached press release (Exhibit 99.1).
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It serves as a notification of the results rather than a detailed financial statement. The Company reports both GAAP and non-GAAP financial measures. Non-GAAP measures exclude items such as impairment charges, restructuring charges, acquisition-related charges, and operating results from exited or held-for-sale businesses to better reflect underlying operational trends.
Material Changes and Adjustments
The filing outlines specific adjustments made to reported results for the twelve months ended December 31, 2017, compared to 2016, to derive non-GAAP figures. Adjustments for 2017 include:
- Amortization expense related to acquired intangible assets.
- Operating results attributable to held-for-sale businesses.
- Impairment charges and restructuring charges.
- Gain/Loss on divestitures and unusual litigation.
- Acquisition charges and contingent consideration adjustments.
- Specific operating results for Entocort, Belgium distribution sales, and API net sales.
- Foreign currency translation movements.
Adjustments for the 2016 period included operating results for held-for-sale businesses, Entocort, Belgium distribution sales, API net sales, and foreign currency translation movements.
Guidance, Outlook, and Management Commentary
Management utilizes these non-GAAP measures for planning, forecasting, and evaluating segment performance. The Company states that these measures facilitate comparability between periods and with competitors by excluding exogenous impacts like foreign exchange and one-time charges. No specific forward-looking guidance or risk factors are detailed within the text of this 8-K filing itself; investors are directed to the attached press release for further commentary.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for 2017.
- Verify the reconciliation between GAAP and non-GAAP financial measures to understand the impact of excluded items.
- Assess the magnitude of foreign currency translation impacts on reported sales growth.
- Confirm the status of held-for-sale businesses and any pending divestitures mentioned in the adjustments.
- Check for any updates on the Entocort operating results and API net sales exclusions.